Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Naltrexone for Nonsuicidal Self-Injurious Behavior
NCT07641283Not yet recruiting
- Sponsor
- Seoul National University Hospital
- Start
- Jun 2026
- Primary completion
- Dec 2027
- Countries
- 1
01
Overview
Randomised, double-blind trial in nonsuicidal self-injury (NSSI) comparing Naltrexone Group with Placebo Group (2 arms). Primary endpoint: Total Number of Nonsuicidal Self-Injury Episodes at 6 weeks. Planned start Jun 2026; status: not yet recruiting.
02
Drugs
naltrexone
03
Conditions
nonsuicidal self-injury (NSSI)
Beyond the preview
Go deeper on NCT07641283.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07641283.